Gsk (GLAXF) Debt Ratio (2009 - 2026)

Gsk's Debt Ratio history runs 18 years deep, the most recent figure standing at 0.22 for Q1 2026.

• In Q1 2026, Debt Ratio rose 17.87% year-over-year to 0.22; the TTM figure through Mar 2026 stood at 0.22 (up 17.87% YoY), while the FY2025 annual figure was 0.19, down 167.14% from the prior year.
• Debt Ratio was 0.22 for Q1 2026 at Gsk, down from 0.19 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.31 in Q4 2023 to a low of 0.32 in Q3 2022.
• Historically, Debt Ratio has averaged 0.15 across 5 years, with a median of 0.23 in 2024.
• The sharpest annual moves came in 2022 and 2025: Debt Ratio increased 29.55% in 2022, then slumped 167.14% in 2025.
• A 5-year view of Debt Ratio shows it stood at 0.3 in 2022, then gained by 0.16% to 0.31 in 2023, then decreased by 6.59% to 0.29 in 2024, then plunged by 167.14% to 0.19 in 2025, then slipped by 16.46% to 0.22 in 2026.
• The last three Debt Ratio figures came in at 0.22 (Q1 2026), 0.19 (Q4 2025), and 0.24 (Q3 2025), per Business Quant data.